"Chart & Float" Today's Top summary picks: Chart

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Pro Music Rights Embarks on a New Financial Journey In an important move towards greater accountability, Music Licensing, Inc. (OTC: SONG), also recognized as Pro Music Rights, has announced its intention to hire a PCAOB-registered audit firm to perform annual audits. This step reflects the company's dedication to enhancing the integrity of its financial reporting and...

The Importance of Foreign Investment in China's Growth Strategy Foreign investment plays a pivotal role in shaping China’s robust economic landscape, a sentiment echoed by a growing number of experts and stakeholders. A recent wave of inquiries about the necessity of foreign investment for China's ongoing development highlights this matter as a crucial topic. This...

Significant Lease Extensions for CityBee at Cuprum CityBee, a prominent joint venture in the UK office sector, has recently achieved a significant milestone by securing two critical lease extensions at Cuprum. This exciting development, involving major tenants, highlights when the future of office spaces is considered, the increasing demand for high-quality and...

Geospatial Solutions: A Market on the Rise The global geospatial solution market is gearing up for remarkable growth, estimated to reach approximately USD 545.7 billion soon and surpassing an impressive USD 2,061.3 billion in the coming years. This upward trajectory represents a compound annual growth rate (CAGR) of 14.2% projected between now and 2035, showcasing a...

Progyny got rocked back in 2024 when news broke that Amazon ditched them for Maven Clinic's fertility benefits. You could feel the desks shuddering as this big player made its move, shaking up the entire landscape. This shift was like a punch to the gut for Progyny, especially since Amazon had been a key client. That loss wasn’t just some random hit; it was a direct...